AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that ...
AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the ...
AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
Apollo Endosurgery enrolled the first patient in a multi-center randomized controlled trial endoscopic sleeve gastroplasty using Apollo's OverStitch Endoscopic Suturing System in patients with ...
OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...
AUSTIN, Texas--(BUSINESS WIRE)-- Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that ...
Shares of Apollo Endosurgery Inc. rocketed 28% in premarket trade Tuesday, after the medical device company said the Food and Drug Administration cleared its new flexibile endoscopic suturing system, ...
Apollo Endosurgery enrolled the first patient in a multi-center randomized controlled trial endoscopic sleeve gastroplasty using Apollo’s OverStitch Endoscopic Suturing System in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results